Elad S, Galili D, Garfunkel A A, Or R
Department of Oral Medicine, Hadassah-Hebrew University-School of Dental Medicine, Jerusalem, Israel.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct;84(4):362-4. doi: 10.1016/s1079-2104(97)90032-9.
Thalidomide was administered as a therapeutic agent for chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in a patient with breast cancer. Although side effects of thalidomide have been described earlier, this is the first instance of perioral neuropathy associated with thalidomide treatment. Awareness of this specific side effect may contribute to early diagnosis and appropriate treatment.